Literature DB >> 10374865

Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors.

S Uzunoglu1, R Uslu, M Tobu, G Saydam, E Terzioglu, F Buyukkececi, S B Omay.   

Abstract

To elucidate the roles of serine/threonine protein phosphatases type 1 (PP1) and type 2A (PP2A) in methylprednisolone-induced differentiation of HL60 cells into granulocytes and K562 cells into monocytes, we examined the effect of serine/threonine protein phosphatase inhibitors, okadaic acid and Cal-A on the proliferation/differentiation of HL60 and K562 cells. Okadaic acid and Cal-A augmented methylprednisolone induced granulocytic differentiation and cell death of HL60 cells and monocytic differentiation and cell death of K562 cells in different dose ranges, respectively. These data suggest an important role of PP1 and PP2A in the mechanism leading to differentiation of leukemic cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10374865     DOI: 10.1016/s0145-2126(99)00040-5

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  Colony-stimulating factor-1 (CSF-1) receptor-mediated macrophage differentiation in myeloid cells: a role for tyrosine 559-dependent protein phosphatase 2A (PP2A) activity.

Authors:  K A McMahon; N J Wilson; D C Marks; T L Beecroft; G A Whitty; J A Hamilton; X F Csar
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

Review 2.  Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.

Authors:  Godfrey Grech; Shawn Baldacchino; Christian Saliba; Maria Pia Grixti; Robert Gauci; Vanessa Petroni; Anthony G Fenech; Christian Scerri
Journal:  Tumour Biol       Date:  2016-07-21

3.  Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1.

Authors:  Samia Yazid; Egle Solito; Helen Christian; Simon McArthur; Nicolas Goulding; Roderick Flower
Journal:  Biochem Pharmacol       Date:  2009-03-24       Impact factor: 5.858

Review 4.  PP2A-Mediated Anticancer Therapy.

Authors:  Weibo Chen; Zhongxia Wang; Chunping Jiang; Yitao Ding
Journal:  Gastroenterol Res Pract       Date:  2013-11-07       Impact factor: 2.260

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.